Allarity Therapeutics
About Allarity Therapeutics
Allarity Therapeutics (Nasdaq: ALLR) is a clinical-stage precision medicine company actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. The company is leveraging its proprietary, highly accurate Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. Publicly traded on NASDAQ, Allarity (ALLR) is headquartered in Boston, MA, while maintaining an R&D facility in Hoersholm, Denmark. Allarity is committed to enhancing patient outcomes through improved decision-making and personalized cancer care.
Find Allarity Therapeutics Execs' Valid Emails
Up to 90% verified emails and mobile numbers, refreshed weekly.
Company Details
0-500K
Pharmaceutical Manufacturing
11-50 employees
Public Company
Boston, Massachusetts
United States
Frequently Asked Questions about
What is Allarity Therapeutics's industry?
Allarity Therapeutics operates in the Pharmaceutical Manufacturing industry and is headquartered in United States.
How many employees does Allarity Therapeutics have?
Allarity Therapeutics has approximately 11-50 employees employees.
Where is Allarity Therapeutics's based?
Allarity Therapeutics is based in Boston, Massachusetts, United States.
Is Allarity Therapeutics publicly listed?
Yes. Allarity Therapeutics is a publicly traded company.
How can I contact Allarity Therapeutics's investor relations team?
You can reach Allarity Therapeutics’s investor relations department through the contact section on their official website or directly via the investor relations email listed in their latest SEC filings.
Find verified emails and phone numbers for professionals like those at
Up to 90% verified emails and mobile numbers, backed by weekly job-change alerts.
Find verified emails at this company
An email pattern tells you the format. It does not tell you who works there now or whether an address still delivers. Scalelist returns verified contacts, checked at the point you build the list.